Comparative Evaluation of Neuroprotective Activity of Tryptanthrin and Its Oxime in Middle Cerebral Artery Occlusion in Rats
| Parent link: | Bulletin of Experimental Biology and Medicine=Бюллетень экспериментальной биологии и медицины.— .— New York: Springer Science+Business Media LLC. Vol. 177, iss. 3.— 2024.— P. 344–348 |
|---|---|
| Yhteisötekijä: | National Research Tomsk Polytechnic University (570) |
| Muut tekijät: | Chernysheva, Smol’iakova V. I. Vera Ivanovna, Plotnikov M. B., Ulyakhina O. A., Osipenko A. N. Anton Nikolaevich, Kovrizhina A. R. Anastasia Ruslanovna, Khlebnikov A. I. Andrey Ivanovich |
| Yhteenveto: | Title screen The neuroprotective activity of tryptanthrin and its oxime was compared in male Wistar rats with a model of intraluminal occlusion of the middle cerebral artery. Neurobehavioral tests were performed 4, 24, and 48 h after focal cerebral infarction (FCI) using a modified neurological severity score (mNSS); additionally, the horizontal stability test, the plantar sensitivity test of the fore and hind limbs, holding on the tilted cage top test, and negative geotaxis test were performed. The size of FCI and the severity of brain tissue swelling were examined on day 2 after occlusion. Tryptanthrin and its oxime were administered at a dose of 10 mg/kg intraperitoneally during FCI, then daily for 2 days. In the control group, the mean score of neurological deficit remained at a high level for 2 days. FCI size was 43.8±3.4% of hemisphere area, and the hemisphere volume increased by 18.5±2.0% due to brain tissue swelling and edema. Administration of tryptanthrin and its oxime significantly decreased neurological deficits at all control points and reduced FCI size (by 24.2 and 30.4%, respectively) and brain tissue swelling of the affected hemisphere (by 64.9 and 62.7%, respectively). Therefore, the neuroprotective effect of tryptanthrine and its oxime in the acute period of FCI is largely determined by their anti-inflammatory activity Текстовый файл AM_Agreement |
| Kieli: | englanti |
| Julkaistu: |
2024
|
| Aiheet: | |
| Linkit: | https://doi.org/10.1007/s10517-024-06186-w Статья на русском языке |
| Aineistotyyppi: | Elektroninen Kirjan osa |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=675573 |
Samankaltaisia teoksia
Neuroprotective Effects of Tryptanthrin-6-Oxime in a Rat Model of Transient Focal Cerebral Ischemia; Pharmaceuticals; Vol. 16, iss. 8
Julkaistu: (2023)
Julkaistu: (2023)
Therapeutic Effects of Tryptanthrin and Tryptanthrin-6-Oxime in Models of Rheumatoid Arthritis; Frontiers in Pharmacology; Vol. 11
Julkaistu: (2020)
Julkaistu: (2020)
Synthesis and biological evaluation of alkali metal salts of tryptanthrin-6-oxime; 53rd International Union of Pure & Applied Chemistry General Assembly (IUPAC 2025) and 50th World Chemistry Congress (50WCC)
Tekijä: Kovrizhina A. R. Anastasia Ruslanovna
Julkaistu: (2025)
Tekijä: Kovrizhina A. R. Anastasia Ruslanovna
Julkaistu: (2025)
Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors; European Journal of Medicinal Chemistry; Vol. 161
Julkaistu: (2018)
Julkaistu: (2018)
Novel Tryptanthrin Derivatives with Selectivity as c–Jun N–Terminal Kinase (JNK) 3 Inhibitors; Molecules; Vol. 28, iss. 12
Julkaistu: (2023)
Julkaistu: (2023)
Design, synthesis and biological evaluation of novel O-substituted tryptanthrin oxime derivatives as c-Jun N-terminal kinase inhibitors; Frontiers in Pharmacology; Vol. 13
Julkaistu: (2022)
Julkaistu: (2022)
The IQ-1S JNK (c-Jun N-Terminal Kinase) Inhibitor Suppresses Premature Aging of OXYS Rat Brain; Neurochemical Journal; Vol. 17, iss. 3
Julkaistu: (2023)
Julkaistu: (2023)
Ethyl 5-Oxo-5-(((12-oxoindolo[2,1-b]quinazolin-6(12H)-ylidene)amino)oxy)pentanoate; Molbank; Vol. 2022, iss. 4
Julkaistu: (2022)
Julkaistu: (2022)
Cardioprotective Effects of a Selective c-Jun N-terminal Kinase Inhibitor in a Rat Model of Myocardial Infarction; Biomedicines; Vol. 11, iss. 3
Julkaistu: (2023)
Julkaistu: (2023)
Vasoactive and Neuroprotective Effects of c-Jun N-Terminal Kinase Inhibitor in Rats with Chronic Cerebral Hypoperfusion; Journal of Evolutionary Biochemistry and Physiology; Vol. 59, iss. 3
Julkaistu: (2023)
Julkaistu: (2023)
Effect of IQ-1 on the Infarct Size and the Parameters of Cardiodynamic Indicators in the Acute Period after Myocardial Ischemia/Reperfusion in Rats; Bulletin of Experimental Biology and Medicine; Vol. 176, iss. 4
Julkaistu: (2024)
Julkaistu: (2024)
Experimental and Computational Investigation of the Oxime Bond Stereochemistry in c-Jun N-terminal Kinase 3 Inhibitors 11H-Indeno[1,2-b]quinoxalin-11-one Oxime and Tryptanthrin-6-oxime; Pharmaceutics; Vol. 15, iss. 7
Julkaistu: (2023)
Julkaistu: (2023)
Protective Effects of a New C-Jun N-terminal Kinase Inhibitor in the Model of Global Cerebral Ischemia in Rats; Molecules; Vol. 24, iss. 9
Julkaistu: (2019)
Julkaistu: (2019)
Neuroprotective Effects of the Lithium Salt of a Novel JNK Inhibitor in an Animal Model of Cerebral Ischemia-Reperfusion; Biomedicines; Vol. 10, iss. 9
Julkaistu: (2022)
Julkaistu: (2022)
Therapeutic Effect of Novel Cyanopyrrolidine-Based Prolyl Oligopeptidase Inhibitors in Rat Models of Amnesia; Frontiers in Chemistry; Vol. 9
Julkaistu: (2021)
Julkaistu: (2021)
Development and validation of HPLC-UV method for quantitation of a new antithrombotic drug in rat plasma and its application to pharmacokinetic studies; Journal of Chromatography B; Vol. 1160
Julkaistu: (2020)
Julkaistu: (2020)
Oximes: Novel Therapeutics with Anticancer and Anti-Inflammatory Potential; Biomolecules; Vol. 11, iss. 6
Julkaistu: (2021)
Julkaistu: (2021)
JNK Signaling Pathway Activity Alterations in the Rat Hippocampus: Effect of Age, Alzheimer’s Disease-Like Pathology Development, and the JNK Inhibitor IQ-1S; Biochemistry (Moscow); Vol. 90, iss. 2
Julkaistu: (2025)
Julkaistu: (2025)
Pharmacokinetics of a New Neuroprotector — Indenoquinoxalinone Derivative after Intravenous Administration in Rabbits and Rats; Bulletin of Experimental Biology and Medicine; Vol. 175, iss. 6
Julkaistu: (2023)
Julkaistu: (2023)
Alterations of JNK Signaling Pathway Activity in the Rat Retina: Effects of Age, Age-Related Macular Degeneration-like Pathology, and a JNK Inhibitor (IQ-1S); Cells; Vol. 14, iss. 12
Julkaistu: (2025)
Julkaistu: (2025)
Neuroprotective effects of p-tyrosol after the global cerebral ischemia in rats; Phytomedicine; Vol. 23, iss. 7
Julkaistu: (2016)
Julkaistu: (2016)
c-Jun N-Terminal Kinases (JNKs) in Myocardial and Cerebral Ischemia/Reperfusion Injury; Frontiers in Pharmacology; Vol. 9
Julkaistu: (2018)
Julkaistu: (2018)
Role of protein kinase C, PI3 kinase, tyrosine kinases, NO-synthase, KATP channels and MPT pore in the signaling pathway of the cardioprotective effect of chronic continuous hypoxia; General Physiology and Biophysics; Vol. 37, iss. 5
Julkaistu: (2018)
Julkaistu: (2018)
Regulation of Blood–Brain Barrier Permeability via JNK Signaling Pathway: Mechanisms and Potential Therapeutic Strategies for Ischemic Stroke, Alzheimer’s Disease and Brain Tumors; Molecules; Vol. 30, iss. 11
Julkaistu: (2025)
Julkaistu: (2025)
A review of Brain-Computer Interface technology; Control and Communications (SIBCON)
Tekijä: Stankevich Ph. V. Philippe Vladimirovich
Julkaistu: (2015)
Tekijä: Stankevich Ph. V. Philippe Vladimirovich
Julkaistu: (2015)
Antihypertensive activity of a new c-Jun N-terminal kinase inhibitor in spontaneously hypertensive rats; Hypertension Research; Vol. 43
Julkaistu: (2020)
Julkaistu: (2020)
Suppression of Age-Related Macular Degeneration-like Pathology by c-Jun N-Terminal Kinase Inhibitor IQ-1S; Biomedicines; Vol. 11, iss. 2
Julkaistu: (2023)
Julkaistu: (2023)
Выявление факторов риска острого инфаркта миокарда с помощью OLAP технологии; Информационные технологии в науке, управлении, социальной сфере и медицине; Ч. 1
Tekijä: Зяблецев П. А.
Julkaistu: (2018)
Tekijä: Зяблецев П. А.
Julkaistu: (2018)
Evaluation of Nitric Oxide-Donating Properties of 11H-indeno[1,2-b]quinoxalin-11-one Oxime (IQ-1) by Electron Paramagnetic Resonance Spectroscopy; Molecules; Vol. 29, iss. 16
Julkaistu: (2024)
Julkaistu: (2024)
Magnetoelectric effect: principles and applications in biology and medicine– a review; Materials Today Bio; Vol. 12
Julkaistu: (2021)
Julkaistu: (2021)
Патоморфологические особенности регенерации конъюнктивы и склеры на фоне интраоперационной аппликации раствора циклоспорина А; Бюллетень сибирской медицины; Т. 18, № 3
Julkaistu: (2019)
Julkaistu: (2019)
Music influence on athlete`s sportsmanship (from the example ofsynchronized figure skating athletes); Journal of Economics and Social Sciences; № 12
Tekijä: Bredikhina Yu. P. Yuliya Petrovna
Julkaistu: (2018)
Tekijä: Bredikhina Yu. P. Yuliya Petrovna
Julkaistu: (2018)
Электроэнцефалограф на наносенсорах для регистрации биопотенциалов мозга в диапазоне частот до 10КГЦ; Ресурсоэффективные системы в управлении и контроле: взгляд в будущее (т. 2)
Julkaistu: (2018)
Julkaistu: (2018)
Neuroprotective Effects of a Novel Inhibitor of c-Jun N-Terminal Kinase in the Rat Model of Transient Focal Cerebral Ischemia; Cells; Vol. 9, iss. 8
Julkaistu: (2020)
Julkaistu: (2020)
Identification of L- and T-type Ca2+ channels in rat cerebral arteries: role in myogenic tone development; American Journal of Physiology - Heart and Circulatory Physiology; Vol. 304, № 1
Julkaistu: (2013)
Julkaistu: (2013)
Анализ многомерных данных для определения группы риска сердечно-сосудистых заболеваний; Информационные технологии в науке, управлении, социальной сфере и медицине; Ч. 1
Tekijä: Зяблецев П. А.
Julkaistu: (2018)
Tekijä: Зяблецев П. А.
Julkaistu: (2018)
Research on neural network analysis of MRI images of the brain for the diagnosis of brain diseases; Молодежь и современные информационные технологии
Tekijä: Tekere R. Richard
Julkaistu: (2025)
Tekijä: Tekere R. Richard
Julkaistu: (2025)
Brain Tractography in Diabetes Mellitus and Cognitive Impairments; Neuroscience and Behavioral Physiology; Vol. 51, No. 6
Julkaistu: (2021)
Julkaistu: (2021)
An Efficient Hybrid Fuzzy-Clustering Driven 3D-Modeling of Magnetic Resonance Imagery for Enhanced Brain Tumor Diagnosis; Electronics; Vol. 9, iss. 3
Julkaistu: (2020)
Julkaistu: (2020)
c-Jun N-Terminal Kinases and Their Pharmacological Modulation in Ischemic and Reperfusion Brain Injury; Neuroscience and Behavioral Physiology; Vol. 48, iss. 6
Julkaistu: (2019)
Julkaistu: (2019)
Samankaltaisia teoksia
-
Neuroprotective Effects of Tryptanthrin-6-Oxime in a Rat Model of Transient Focal Cerebral Ischemia; Pharmaceuticals; Vol. 16, iss. 8
Julkaistu: (2023) -
Therapeutic Effects of Tryptanthrin and Tryptanthrin-6-Oxime in Models of Rheumatoid Arthritis; Frontiers in Pharmacology; Vol. 11
Julkaistu: (2020) -
Synthesis and biological evaluation of alkali metal salts of tryptanthrin-6-oxime; 53rd International Union of Pure & Applied Chemistry General Assembly (IUPAC 2025) and 50th World Chemistry Congress (50WCC)
Tekijä: Kovrizhina A. R. Anastasia Ruslanovna
Julkaistu: (2025) -
Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors; European Journal of Medicinal Chemistry; Vol. 161
Julkaistu: (2018) -
Novel Tryptanthrin Derivatives with Selectivity as c–Jun N–Terminal Kinase (JNK) 3 Inhibitors; Molecules; Vol. 28, iss. 12
Julkaistu: (2023)